Partner Content Partner Content WHO's Senior Advisor to speak at 21st Annual Superbugs &... WHO to speak at 21st Superbugs & Superdrugs 2019
Partner Content Partner Content Challenges including Funding and Lack of Incentives Hinder A... Explore Challenges in Antibiotic Research
Partner Content Partner Content Registration Officially Opens for the 21st Annual Superbugs ... Registration Opens for 21st Superbugs & Superdrugs 2019
Events Partner Content 21st Annual Superbugs & Superdrugs Conference 21st Annual Superbugs & Superdrugs Conference
Partner Content Partner Content W. J. Wiess and A.S. Lynch invitation to Superbugs & Sup... SMi Group reports: William J.
News UK government kick-starts AMR research with £10m grant Tackling AMR is long-term government goal
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.